187 related articles for article (PubMed ID: 17762391)
1. Establishment and gene analysis of an oxaliplatin-resistant colon cancer cell line THC8307/L-OHP.
Tang H; Liu YJ; Liu M; Li X
Anticancer Drugs; 2007 Jul; 18(6):633-9. PubMed ID: 17762391
[TBL] [Abstract][Full Text] [Related]
2. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
3. 5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro.
Zhou J; Zhou Y; Yin B; Hao W; Zhao L; Ju W; Bai C
Oncol Rep; 2010 Jan; 23(1):121-8. PubMed ID: 19956872
[TBL] [Abstract][Full Text] [Related]
4. Reduced drug accumulation is more important in acquired resistance against oxaliplatin than against cisplatin in isogenic colon cancer cells.
Ekblad L; Kjellström J; Johnsson A
Anticancer Drugs; 2010 Jun; 21(5):523-31. PubMed ID: 20168208
[TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
[TBL] [Abstract][Full Text] [Related]
6. cDNA microarray-based identification of genes and pathways associated with oxaliplatin resistance.
Samimi G; Manorek G; Castel R; Breaux JK; Cheng TC; Berry CC; Los G; Howell SB
Cancer Chemother Pharmacol; 2005 Jan; 55(1):1-11. PubMed ID: 15378272
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of nuclear factor I/B in oxaliplatin-resistant human cancer cell lines.
Kashiwagi E; Izumi H; Yasuniwa Y; Baba R; Doi Y; Kidani A; Arao T; Nishio K; Naito S; Kohno K
Cancer Sci; 2011 Feb; 102(2):382-6. PubMed ID: 21087353
[TBL] [Abstract][Full Text] [Related]
8. S100P contributes to chemosensitivity of human ovarian cancer cell line OVCAR3.
He Z; Gao J; Wang Q; Liu M; Li Y; Li X; Tang H; Zheng J
Oncol Rep; 2008 Aug; 20(2):325-32. PubMed ID: 18636193
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer.
Boyer J; Allen WL; McLean EG; Wilson PM; McCulla A; Moore S; Longley DB; Caldas C; Johnston PG
Cancer Res; 2006 Mar; 66(5):2765-77. PubMed ID: 16510598
[TBL] [Abstract][Full Text] [Related]
10. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
Samimi G; Kishimoto S; Manorek G; Breaux JK; Howell SB
Cancer Chemother Pharmacol; 2007 Feb; 59(3):301-12. PubMed ID: 16770583
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study on human colonic-cancer cell line, DLD-1 and the 5-FU resistant cell line].
Ito R
Hokkaido Igaku Zasshi; 2004 Jul; 79(4):413-25. PubMed ID: 15373213
[No Abstract] [Full Text] [Related]
12. Oxaliplatin-induced mitochondrial apoptotic response of colon carcinoma cells does not require nuclear DNA.
Gourdier I; Crabbe L; Andreau K; Pau B; Kroemer G
Oncogene; 2004 Sep; 23(45):7449-57. PubMed ID: 15334062
[TBL] [Abstract][Full Text] [Related]
13. [Roles of hMMS2 gene in reversing the oxaliplatin tolerance of human colon carcinoma cells].
Zhang L; Sui Y; Wang T; Li L; Li Y; Jin C; Xu F
Yi Chuan; 2014 Apr; 36(4):346-53. PubMed ID: 24846979
[TBL] [Abstract][Full Text] [Related]
14. Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling.
Maxwell PJ; Longley DB; Latif T; Boyer J; Allen W; Lynch M; McDermott U; Harkin DP; Allegra CJ; Johnston PG
Cancer Res; 2003 Aug; 63(15):4602-6. PubMed ID: 12907638
[TBL] [Abstract][Full Text] [Related]
15. Cross-resistance of platinum derivatives in H-1R, a cisplatin-resistant cell line.
Negoro K; Yamano Y; Nakashima D; Saito K; Nakatani K; Shiiba M; Bukawa H; Yokoe H; Uzawa K; Wada T; Tanzawa H; Fujita S
Oncol Rep; 2009 Feb; 21(2):443-9. PubMed ID: 19148521
[TBL] [Abstract][Full Text] [Related]
16. Impact of oxaliplatin and a novel DACH-platinum complex in the gene expression of HCT116 colon cancer cells.
Pang SK; Yu CW; Guan H; Au-Yeung SC; Ho YP
Oncol Rep; 2008 Nov; 20(5):1269-76. PubMed ID: 18949432
[TBL] [Abstract][Full Text] [Related]
17. Establishment and biological characteristics of oxaliplatin-resistant human colon cancer cell lines.
Liu Z; Qiu M; Tang QL; Liu M; Lang N; Bi F
Chin J Cancer; 2010 Jul; 29(7):661-7. PubMed ID: 20591218
[TBL] [Abstract][Full Text] [Related]
18. Monitoring the gene expression profiles of doxorubicin-resistant acute myelocytic leukemia cells by DNA microarray analysis.
Song JH; Choi CH; Yeom HJ; Hwang SY; Kim TS
Life Sci; 2006 Jun; 79(2):193-202. PubMed ID: 16458935
[TBL] [Abstract][Full Text] [Related]
19. Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.
Györffy B; Serra V; Jürchott K; Abdul-Ghani R; Garber M; Stein U; Petersen I; Lage H; Dietel M; Schäfer R
Oncogene; 2005 Nov; 24(51):7542-51. PubMed ID: 16044152
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]